Compulsory licensing is not the answer
Brian Ager, Director General, European Federation of Pharmaceutical Industries and Associations
We believe the WTO agreement on August 30 on the issue of
compulsory licences for export, that is to make the existing
flexibilities of the TRIPs Agreement accessible to members lacking
domestic manufacturing capacity in the pharmaceutical sector,
demonstrates the value of the multilateral...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.